Paper3383205
Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.
Guadagni F and 4 others. Cancer Immunol Immunother, 1988. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon. Papers, record 3383205. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3383205
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Immunologic | Major topic |
| Antibodies, Monoclonal | Major topic |
| Carcinoma | Major topic |
| Interferon Type I | Major topic |
| Recombinant Proteins | Major topic |
| Animals | |
| Binding Sites, Antibody | |
| Breast Neoplasms | |
| Cell Line | |
| Colonic Neoplasms | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Neoplasm Transplantation |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2424575 | Modulation of antigen expression in human tumor cell populations. | Cancer Invest | 1986 | https://conductscience.org/library/papers/2424575 | PubMed |
| 2 | 3843352 | Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferons. | Pharmacol Ther | 1985 | https://conductscience.org/library/papers/3843352 | PubMed |
| 3 | 6170263 | Antiproliferative and antiviral activities of human leukocyte interferons. | Arch Biochem Biophys | 1981 | https://conductscience.org/library/papers/6170263 | PubMed |
| 4 | 6176159 | Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/6176159 | PubMed |
| 5 | 3160671 | Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression. | Int J Cancer | 1985 | https://conductscience.org/library/papers/3160671 | PubMed |
| 6 | 3096562 | Enhancement by gamma-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen. | Cancer Res | 1986 | https://conductscience.org/library/papers/3096562 | PubMed |
| 7 | 6622704 | Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments. | Radiology | 1983 | https://conductscience.org/library/papers/6622704 | PubMed |
| 8 | 6747299 | Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. | J Immunol | 1984 | https://conductscience.org/library/papers/6747299 | PubMed |
| 9 | 25290651 | Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. | Immunol Today | 1981 | https://conductscience.org/library/papers/25290651 | PubMed |
| 10 | 719607 | Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy. | Cancer | 1978 | https://conductscience.org/library/papers/719607 | PubMed |
| 11 | 6744259 | Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment. | Cancer Res | 1984 | https://conductscience.org/library/papers/6744259 | PubMed |
| 12 | 3957460 | Use of monoclonal antibodies to human breast-tumor-associated antigens in fine-needle aspirate cytology. | Int J Cancer | 1986 | https://conductscience.org/library/papers/3957460 | PubMed |
| 13 | 2944575 | Differential effects of recombinant human leukocyte interferons on cell surface antigen expression. | Cancer Res | 1986 | https://conductscience.org/library/papers/2944575 | PubMed |
| 14 | 5432063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 15 | 3698030 | Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer. | Cancer Res | 1986 | https://conductscience.org/library/papers/3698030 | PubMed |
| 16 | 3940648 | Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. | Cancer Res | 1986 | https://conductscience.org/library/papers/3940648 | PubMed |
| 17 | 6589637 | A species of human alpha interferon that lacks the ability to boost human natural killer activity. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6589637 | PubMed |
| 18 | 6164056 | Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6164056 | PubMed |
| 19 | 6159538 | Human leukocyte interferon produced by E. coli is biologically active. | Nature | 1980 | https://conductscience.org/library/papers/6159538 | PubMed |
| 20 | 3088107 | A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. | J Immunol | 1986 | https://conductscience.org/library/papers/3088107 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27581603 | A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/27581603 | PubMed |
| 10459728 | Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging. | Drugs Aging | 1999 | https://conductscience.org/library/papers/10459728 | PubMed |
| 2675955 | The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites. | Br J Cancer | 1989 | https://conductscience.org/library/papers/2675955 | PubMed |
| 2248992 | Quantification of transport and binding parameters using fluorescence recovery after photobleaching. Potential for in vivo applications. | Biophys J | 1990 | https://conductscience.org/library/papers/2248992 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3383205
GET https://conductscience.org/api/papers/v1/3383205/references?page=2